Source comparison
CJC-1295 No DAC & Ipamorelin Dosage: Research Protocol Comparison
Below is a comparison of standard research dosing protocols documented in peer-reviewed growth hormone secretagogue studies, showing how dosage varies by research objective and administration timing. Standard Combination 100mcg (fixed) 200mcg or 2–3mcg/kg Once
This comparison does not assign a generated winner or score.
- Below is a comparison of standard research dosing protocols documented in peer-reviewed growth hormone secretagogue studies, showing how dosage varies by research objective and administration timing.
- Standard Combination
- 100mcg (fixed)
- 200mcg or 2–3mcg/kg
- Once daily
- 30–60 min before sleep
- GH pulse amplitude optimization during nocturnal secretion window
- Body Weight-Adjusted
- 1–3mcg/kg (70–210mcg for 70kg subject)
- Evening, pre-sleep
- Individualized dosing based on lean body mass and IGF-1 response
- Twice-Daily Pulsatile
- 100mcg
- 100–150mcg
- Twice daily
- Morning upon waking + evening pre-sleep
- Mimicking natural pulsatile GH secretion pattern with dual peaks
- High-Amplitude Single Dose
- 200mcg
- 300mcg
- Immediately before sleep
- Maximum single-dose GH pulse for short-term research interventions